Related topics
| Topic | Replies | Views | Activity | |
|---|---|---|---|---|
| Effects of Long-Term Deutetrabenazine Treatment in Patients with Tardive Dyskinesia and Underlying Psychiatric or Mood Disorders | 0 | 210 | April 28, 2022 | |
| Unique and overlapping mechanisms of valbenazine, deutetrabenazine, and vitamin E for tardive dyskinesia | 1 | 39 | April 24, 2025 | |
| Antipsychotic Dose Reduction Increases Mental Health-Related and All-Cause Hospitalizations | 0 | 359 | October 12, 2018 | |
| Two New Drugs for Tardive Dyskinesia Hit the Market | 5 | 877 | January 4, 2018 | |
| Biotech Company - Neurocrine - FDA approves first drug for tardive dyskinesia | 3 | 1108 | April 12, 2017 |